You have 9 free searches left this month | for more free features.

City

New York (1)

Paris (1)

Turku (1)

Condition

AIDS Vacuolar Myelopathy (1)

AIDS-Myelopathy (1)

Mutation Ala393Thr of the MARS Gene (1)

Myelopathy (1)

Pulmonary Alveolar Proteinosis (1)

Pulmonary Sarcoidosis (1)

mutationSer567Leu of the MARS Gene (1)

Overall Status

Completed (2)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Turku University Hospital (1)

Collaborator

Intervention

methionine (3)

abdominal and liver ultrasound. (1)

brain mri (1)

dotanoc (1)

methionine/homocysteine dosage (1)

thoracic ct scan (1)

vitamin b12, b9, b6, c supplementation (1)

Study Documents

Intervention Type

drug (3)

diagnostic test (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

methionine

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pulmonary Alveolar Proteinosis, Mutation Ala393Thr of the MARS Gene, mutationSer567Leu of the MARS Gene Trial in Paris

Completed

Pulmonary Alveolar Proteinosis
+2 more

Methionine
+5 more

Paris, Ile De France, France

Hôpital Necker-Enfants Malades

Nov 6, 2020

Pulmonary Sarcoidosis Trial in Turku (Methionine, DOTANOC)

Unknown status

Pulmonary Sarcoidosis

Methionine
DOTANOC

Turku, Varsinais-Suomi, Finland

Turku University Hospital

Jul 1, 2016

Myelopathy, AIDS-Myelopathy, AIDS Vacuolar Myelopathy Trial in New York (methionine)

Completed

Myelopathy
+2 more

methionine

New York, New York

Beth Israel Medical Center

May 12, 2006